The influence of perceived social support on medication adherence in first-episode psychosis

Canadian Journal of Psychiatry

Volumn 58, Issue 1, 2013, Pages 59-65

  Rabinovitch, Mark ^a,b   Cassidy, Clifford ^a   Schmitz, Norbert ^c   Joober, Ridha ^a,b   Malla, Ashok ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Medication adherence; Psychotic disorders; Social and family support

Indexed keywords

ADULT; ARTICLE; CASE MANAGER; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; FAMILY COUNSELING; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PSYCHOSIS; SOCIAL SUPPORT; SUBSTANCE ABUSE;

EID: 84873027341     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305800111     Document Type: Article

References (27)

1. Robinson DG, Woerner MG, Alvir JM, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 1999;156(4):544-549.
2. Malla AK, Norman RM, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res. 2002;54(3):231-242.
3. Petersen L, Thorup A, Øghlenschlaeger J, et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can J Psychiatry. 2008;53(10):660-670.
4. Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56(3):241-247.
5. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106(4):286-290.
6. Verdoux H, Lengronne J, Liraud F, et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand. 2000;102(3):203-210.
7. Malla AK, Norman RM, Manchanda R, et al. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med. 2002;32(6):1109-1119.
8. Harvey CA, Jeffreys SE, McNaught AS, et al. The Camden Schizophrenia Surveys. III: Five-year outcome of a sample of individuals from a prevalence survey and the importance of social relationships. Int J Soc Psychiatry. 2007;53(4):340-356.
9. Magliano L, Fiorillo A, De Rosa C, et al. Family burden in longterm diseases: a comparative study in schizophrenia vs. physical disorders. Soc Sci Med. 2005;61(2):313-322.
10. Barbato A, D'Avanzo B. Family interventions in schizophrenia and related disorders: a critical review of clinical trials. Acta Psychiatr Scand. 2000;102(2):81-97.
11. Chien WT, Lee IY. The schizophrenia care management program for family caregivers of Chinese patients with schizophrenia. Psychiatr Serv. 2010;61(3):317-320.
12. Chien WT, Thompson DR, Norman I. Evaluation of a peerled mutual support group for Chinese families of people with schizophrenia. Am J Community Psychol. 2008;42(1-2):122-134.
13. Chien WT, Wong KF. A family psychoeducation group program for Chinese people with schizophrenia in Hong Kong. Psychiatr Serv. 2007;58(7):1003-1006.
14. Mattsson M, Topor A, Cullberg J, et al. Association between financial strain, social network and five-year recovery from first episode psychosis. Soc Psychiatry Psychiatr Epidemiol. 2008;43(12):947-952.
15. Norman RM, Malla AK, Manchanda R, et al. Social support and three-year symptom and admission outcomes for first episode psychosis. Schizophr Res. 2005;80(2-3):227-234.
16. Erickson DH, Beiser M, Iacono WG. Social support predicts 5-year outcome in first-episode schizophrenia. J Abnorm Psychol. 1998;107(4):681-685.
17. Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405-411.
18. Anderson B, Ho J, Brackett J, et al. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulindependent diabetes mellitus. J Pediatr. 1997;130(2):257-265.
19. Lyon ME, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDs. 2003;17(6):299-308.
20. Rabinovitch M, Béchard-Evans L, Schmitz N, et al. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry. 2009;54(1):28-35.
21. Novak-Grubic V, Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur Psychiatry. 2002;17(3):148-154.
22. Barrera M Jr. Distinctions between social support concepts, measures and models. Am J Community Psychol. 1986;99(8):413-445.
23. Malla A, Norman R, McLean T, et al. A Canadian programme for early intervention in non-affective psychotic disorders. Aust N Z J Psychiatry. 2003;37(4):407-413.
24. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
25. Amador XF, Flaum M, Andreasen NC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51(10):826-836.
26. Zimet GD, Powell SS, Farley GK, et al. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. 1990;55(3-4):610-617.
27. Cecil H, Stanley MA, Carrion PG, et al. Psychometric properties of the MSPSS and NOS in psychiatric outpatients. J Clin Psychol. 1995;51(5):593-602.